Lee So-Young, Kim Myungshin, Lim Jihyang, Kim Yonggoo, Han Kyungja, Kim Sung Yong, Kim Hee Je, Park In-Yang
Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Korean J Lab Med. 2007 Feb;27(1):19-21. doi: 10.3343/kjlm.2007.27.1.19.
The inv(16)(p13q22) is found in de novo AML and is closely associated with the FAB subtype M4eo. The inv(16) is rarely reported in therapy-related AML (t-AML) patients. Herein, we report a case of t-AML with inv(16) after combination chemotherapy using antimitotic agent and alkylating agent (cis-platin-paclitaxel) for ovarian serous cystadenocarcinoma.